摘要
To explore the clinical characteristics,pathogenesis,and treatment efficacy of patients with stroke warning syndrome(SWS).Methods:Ten patients with internal capsule early warning syndrome who visited the Neurology Department of our hospital from 2019 to 2023 were enrolled.Their clinical data were summarized,and the etiology,pathogenesis,imaging features,and treatment outcomes were discussed in light of previous literature.Results:Among the patients,there were 5 males and 5 females,with an average age of 60 years.The number of attacks ranged from 4 to 9,and the duration of each attack varied from 3 to 60 minutes.Five patients underwent intravenous thrombolysis.Four patients still experienced recurrent attacks after thrombolysis.They were then provided with volume expansion,anticoagulation,antiplatelet aggregation,vasospasm-relief therapies,and symptomatic treatment as appropriate.Three months later,the mRs score of all patients was≤2 points.Conclusion:Although SWS is not common,it is associated with a high risk of early infarction and a poor clinical prognosis.Clinicians should be fully aware of stroke warning syndrome and strive to prevent its clinical progression.
基金
Project of Chengde Municipal Science and Technology Bureau,Project Name:A Comparative Study on the Efficacy and Safety of Tirofiban and Argatroban in the Treatment of Acute Cerebral Infarction.Project Code:202402A045.
